top of page
Latest news


What is personalised cancer medicine?
Learn about personalised medicine and precision medicine in cancer in this short video.
Sep 19, 20231 min read


GSK enters IMPRESS Norway
Two precision medicine drugs from CONNECT partner GSK are the newest additions to the clinical trial IMPRESS.
Sep 5, 20232 min read


Personalised medicine to relieve the health service
Smaller patient groups and targeted treatments are the future of cancer care in Norway.
Aug 21, 20233 min read
Advancing precision cancer medicine via European collaboration
Learn more about the EU-funded Norwegian initiatives PCM4EU and PRIME-ROSE, and the Norwegian MATRIX Centre. Two Norwegian EU-funded...
May 2, 20233 min read

Success criteria for industry-sponsored clinical trials
The third educational seminar in the clinical trials meeting series arranged by CONNECT Working Group 2 took place via Zoom on 13 February.
Feb 28, 20233 min read
CONNECT seminar: investigator-initiated clinical trials
How can researchers have successful collaborations with industry in clinical studies? This was a central question at a recent CONNECT semina
Oct 31, 20225 min read


Inclusion of clinical opinions in economic evaluations
How can clinicians be more involved in healthcare decision-making?
Oct 18, 20221 min read


Kicking off the Clinical Trials meeting series
Industry-sponsored clinical studies in Norway were in focus at the kick-off meeting for a new meeting series hosted by CONNECT Working Group
Sep 26, 20224 min read


The future of precision cancer medicine
The first national initiatives for precision cancer medicine have successfully taken shape in Norway, but what has been achieved and what do
Aug 31, 20224 min read
bottom of page